[go: up one dir, main page]

DE68909242D1 - Adhäsives mittel zur arzneistoffabgabe. - Google Patents

Adhäsives mittel zur arzneistoffabgabe.

Info

Publication number
DE68909242D1
DE68909242D1 DE89912965T DE68909242T DE68909242D1 DE 68909242 D1 DE68909242 D1 DE 68909242D1 DE 89912965 T DE89912965 T DE 89912965T DE 68909242 T DE68909242 T DE 68909242T DE 68909242 D1 DE68909242 D1 DE 68909242D1
Authority
DE
Germany
Prior art keywords
disposing
drugs
adhesive agent
adhesive
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89912965T
Other languages
English (en)
Other versions
DE68909242T2 (de
Inventor
Lisbeth Illum
Paul Williams
Antony James Caston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Danbiosyst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd
Application granted granted Critical
Publication of DE68909242D1 publication Critical patent/DE68909242D1/de
Publication of DE68909242T2 publication Critical patent/DE68909242T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE89912965T 1988-11-08 1989-11-03 Adhäsives mittel zur arzneistoffabgabe. Expired - Fee Related DE68909242T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888826116A GB8826116D0 (en) 1988-11-08 1988-11-08 Adhesive drug delivery composition

Publications (2)

Publication Number Publication Date
DE68909242D1 true DE68909242D1 (de) 1993-10-21
DE68909242T2 DE68909242T2 (de) 1994-02-17

Family

ID=10646485

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89912965T Expired - Fee Related DE68909242T2 (de) 1988-11-08 1989-11-03 Adhäsives mittel zur arzneistoffabgabe.

Country Status (6)

Country Link
US (2) US6355276B1 (de)
EP (1) EP0442949B1 (de)
JP (1) JP2957005B2 (de)
DE (1) DE68909242T2 (de)
GB (2) GB8826116D0 (de)
WO (1) WO1990004963A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310654A (en) * 1985-07-31 1994-05-10 The Board Of Trustees Of The Leland Stanford Junior University Method for determining virulence of Yersinia
GB8826116D0 (en) * 1988-11-08 1988-12-14 Danbiosyst Ltd Adhesive drug delivery composition
JP3296817B2 (ja) * 1991-04-02 2002-07-02 バイオテック・オーストラリア・ピーティーワイ・リミテッド 微粒子に適した経口配布系
ES2109362T3 (es) 1991-06-21 1998-01-16 Univ Cincinnati Unas proteinas administrables oralmente y metodo para hacerlas.
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
DE4120760A1 (de) * 1991-06-24 1993-03-04 3 M Medica Gmbh Traegersysteme fuer arzneimittel
GB2260080A (en) * 1991-10-04 1993-04-07 Rhone Poulenc Rorer Ltd Gelled alginate compositions
ZA934199B (en) * 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh
CA2086631C (en) * 1992-12-22 1998-10-06 J. Gabriel Michael Oral administration of immunologically active biomolecules and other therapeutic proteins
MX9401351A (es) * 1993-02-22 1994-08-31 Alza Corp Composiciones para suministro oral para agentes activos.
GB2279871B (en) * 1993-06-23 1997-05-07 Jevco Ltd Drug retention systems for use in aquaculture
US5562909A (en) * 1993-07-12 1996-10-08 Massachusetts Institute Of Technology Phosphazene polyelectrolytes as immunoadjuvants
EP0792161A4 (de) * 1993-07-12 1998-04-29 Virus Res Inst Mikroverkapselte impfstoffe auf hydrogelbasis
IL110938A (en) * 1994-09-12 2001-01-28 Haber Meir Adhesive proteins isolated from mature macro and microalgae
WO1996013250A1 (en) * 1994-10-27 1996-05-09 Amgem Inc. Compositions for increased bioavailability of orally delivered therapeutic agents
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US7087236B1 (en) 1998-09-01 2006-08-08 Merrion Research I Limited Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
KR100372579B1 (ko) * 2000-06-21 2003-02-17 엘지.필립스 엘시디 주식회사 액정표시장치용 어레이기판과 그 제조방법
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20040126900A1 (en) * 2001-04-13 2004-07-01 Barry Stephen E High affinity peptide- containing nanoparticles
US20030124196A1 (en) * 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
US20030083286A1 (en) * 2001-08-22 2003-05-01 Ching-Leou Teng Bioadhesive compositions and methods for enhanced intestinal drug absorption
AU2003256329A1 (en) * 2002-06-27 2004-01-19 University Of Washington Use of adhesion molecules as bond stress-enhanced nanoscale binding switches
US7682631B2 (en) * 2003-10-01 2010-03-23 Clemson University Adhesin-specific nanoparticles and process for using same
WO2007054310A2 (en) * 2005-11-11 2007-05-18 Universität Regensburg Pyroglue
US8846102B2 (en) * 2006-03-30 2014-09-30 Engene, Inc. Non-viral compositions and methods for transfecting gut cells in vivo
US20080279921A1 (en) * 2007-05-07 2008-11-13 Ceramoptec Industries, Inc. Gel-formulations of hydrophobic photosensitizers for mucosal applications
DK2569430T3 (en) 2010-05-12 2019-02-04 Univ Columbia PROCEDURES FOR MANUFACTURING ENTEROENDOCRIN CELLS WHICH MANUFACTURE AND SECRET INSULIN
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
WO2015200901A1 (en) 2014-06-26 2015-12-30 The Trustees Of Columbia University In The City Of New York Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
US10954300B2 (en) 2015-09-28 2021-03-23 The Trustees Of Columbia University In The City Of New York Use of pentoxifylline with immune checkpoint-blockade therapies for the treatment of melanoma

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
US4443549A (en) * 1981-10-19 1984-04-17 Molecular Genetics, Inc. Production of monoclonal antibodies against bacterial adhesins
JPH0830004B2 (ja) * 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
US5242808A (en) * 1984-09-13 1993-09-07 Enzon, Inc. Production of bioadhesive precursor protein analogs by genetically engineered organisms
US4661345A (en) * 1985-02-26 1987-04-28 The Rockefeller University Method for treating pertussis
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
JPS6323670A (ja) * 1986-04-25 1988-01-30 バイオ−ポリマ−ズ　インコ−ポレ−テツド 接着・被覆組成物とその使用方法
US4851393A (en) * 1986-07-28 1989-07-25 Massachusetts Institute Of Technology Method for utilizing an exocellular polysaccharide isolated from zoogloea ramigera
DE3709101A1 (de) * 1987-03-20 1988-09-29 Mueller Lierheim Kg Biolog Lab Immobilisierungssubstanz
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
GB8826116D0 (en) * 1988-11-08 1988-12-14 Danbiosyst Ltd Adhesive drug delivery composition
US5223604A (en) * 1991-06-25 1993-06-29 S.P.I. Synthetic Peptides Incorporated Pseudomonas exoenzyme s peptide composition and method
ZA934199B (en) * 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh

Also Published As

Publication number Publication date
JPH04502910A (ja) 1992-05-28
US6387408B1 (en) 2002-05-14
DE68909242T2 (de) 1994-02-17
EP0442949B1 (de) 1993-09-15
GB2243778A (en) 1991-11-13
JP2957005B2 (ja) 1999-10-04
GB9109769D0 (en) 1991-07-10
EP0442949A1 (de) 1991-08-28
GB2243778B (en) 1992-06-24
US6355276B1 (en) 2002-03-12
WO1990004963A1 (en) 1990-05-17
GB8826116D0 (en) 1988-12-14

Similar Documents

Publication Publication Date Title
DE68909242D1 (de) Adhäsives mittel zur arzneistoffabgabe.
FI905718L (fi) Transdermalt medel.
FI893340A0 (fi) Foerfarande foer att erhaolla farmaceutiska sammansaettningar foer att hindra smittbara koenssjukdomar.
ATE98480T1 (de) Arzneimittelformulierungen.
DK229489D0 (da) Laegemiddeladsorbater
DE58900730D1 (de) Spritzentablett.
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
DE69019817D1 (de) Trägermaterial zur Arzneimittelverabreichung.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE68904151D1 (de) Rollstuhlvorrichtung.
DE68912814D1 (de) Spritzen.
DE68910469D1 (de) Interdentale Immobilisierungsvorrichtung.
FI893835L (fi) Laekemedel.
DK548689D0 (da) Farmaceutisk oploesning
FI905236A0 (fi) Deoxiribonukleosider innehaollande farmaceutiska konsistenser foer laekning av saor.
DE68910100D1 (de) Mittel zur Bluttrennung.
IS3136A7 (is) Læknislyf handa hrossum.
FI875616A0 (fi) Farmaceutiska blandningar.
FI912644A0 (fi) Antimikrobiskt medel.
ATE94382T1 (de) Adhaesives mittel zur arzneistoffabgabe.
ES1008212Y (es) Biberon desechable perfeccionado.
BR8905094A (pt) Dispositivo de medicao
NO905013L (no) Kanyleanordning.
ATE96636T1 (de) Interdentale immobilisierungsvorrichtung.
LV5735B4 (lv) Medikamenti

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINI

8339 Ceased/non-payment of the annual fee